nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE6H—forebrain—attention deficit hyperactivity disorder	0.0869	0.12	CbGeAlD
Vardenafil—PDE10A—forebrain—attention deficit hyperactivity disorder	0.0565	0.0778	CbGeAlD
Vardenafil—PDE1B—forebrain—attention deficit hyperactivity disorder	0.056	0.0771	CbGeAlD
Vardenafil—PDE6H—nervous system—attention deficit hyperactivity disorder	0.0472	0.065	CbGeAlD
Vardenafil—PDE6H—central nervous system—attention deficit hyperactivity disorder	0.0454	0.0626	CbGeAlD
Vardenafil—PDE11A—brain—attention deficit hyperactivity disorder	0.036	0.0497	CbGeAlD
Vardenafil—PDE6H—brain—attention deficit hyperactivity disorder	0.036	0.0497	CbGeAlD
Vardenafil—PDE5A—forebrain—attention deficit hyperactivity disorder	0.033	0.0455	CbGeAlD
Vardenafil—PDE10A—nervous system—attention deficit hyperactivity disorder	0.0307	0.0422	CbGeAlD
Vardenafil—PDE1B—nervous system—attention deficit hyperactivity disorder	0.0304	0.0419	CbGeAlD
Vardenafil—PDE10A—central nervous system—attention deficit hyperactivity disorder	0.0295	0.0407	CbGeAlD
Vardenafil—PDE1B—central nervous system—attention deficit hyperactivity disorder	0.0293	0.0403	CbGeAlD
Vardenafil—PDE10A—cerebellum—attention deficit hyperactivity disorder	0.0289	0.0398	CbGeAlD
Vardenafil—PDE1B—cerebellum—attention deficit hyperactivity disorder	0.0286	0.0394	CbGeAlD
Vardenafil—PDE5A—cardiovascular system—attention deficit hyperactivity disorder	0.0279	0.0385	CbGeAlD
Vardenafil—PDE10A—brain—attention deficit hyperactivity disorder	0.0234	0.0323	CbGeAlD
Vardenafil—PDE1B—brain—attention deficit hyperactivity disorder	0.0232	0.032	CbGeAlD
Vardenafil—PDE5A—nervous system—attention deficit hyperactivity disorder	0.0179	0.0247	CbGeAlD
Vardenafil—PDE5A—central nervous system—attention deficit hyperactivity disorder	0.0173	0.0238	CbGeAlD
Vardenafil—PDE5A—cerebellum—attention deficit hyperactivity disorder	0.0169	0.0233	CbGeAlD
Vardenafil—PDE11A—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0145	0.053	CbGpPWpGaD
Vardenafil—PDE5A—brain—attention deficit hyperactivity disorder	0.0137	0.0189	CbGeAlD
Vardenafil—PDE10A—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.013	0.0472	CbGpPWpGaD
Vardenafil—PDE11A—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00819	0.0298	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0073	0.0266	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00657	0.0239	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—STUB1—attention deficit hyperactivity disorder	0.00627	0.0229	CbGpPWpGaD
Vardenafil—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00559	0.00771	CbGeAlD
Vardenafil—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00538	0.00742	CbGeAlD
Vardenafil—PDE11A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00482	0.0176	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00454	0.0165	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00429	0.0157	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00429	0.0157	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00412	0.015	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00405	0.0147	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0037	0.0135	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00367	0.0134	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.0033	0.012	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00304	0.0111	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00298	0.0109	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00276	0.0101	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00271	0.00989	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00271	0.00987	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00266	0.00969	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00253	0.00923	CbGpPWpGaD
Vardenafil—PDE6G—Disease—STUB1—attention deficit hyperactivity disorder	0.00248	0.00905	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00246	0.00898	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00243	0.00888	CbGpPWpGaD
Vardenafil—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00243	0.00886	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00241	0.0088	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00235	0.00858	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00226	0.00822	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00226	0.00822	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00223	0.00812	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00218	0.00793	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00217	0.00791	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00207	0.00754	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00205	0.00747	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0019	0.00693	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00188	0.00684	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00186	0.00679	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00184	0.00672	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00181	0.00659	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00174	0.00634	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00173	0.0063	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00169	0.00618	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00168	0.00612	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00167	0.0061	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00164	0.00598	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.00595	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00163	0.00593	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00161	0.00587	CbGpPWpGaD
Vardenafil—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00161	0.00585	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0016	0.00583	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0016	0.00583	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00158	0.00576	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00157	0.00572	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00153	0.00556	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0015	0.00546	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00149	0.00545	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00148	0.00539	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00147	0.00536	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00146	0.00533	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00146	0.00533	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00146	0.00531	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00145	0.00529	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00145	0.00529	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00143	0.00523	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00143	0.00523	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00143	0.0052	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.0052	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00141	0.00513	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0014	0.0051	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00501	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00137	0.005	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00136	0.00496	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00135	0.00491	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00134	0.00487	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STUB1—attention deficit hyperactivity disorder	0.00133	0.00484	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00132	0.0048	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00131	0.00478	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00129	0.00472	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00128	0.00466	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00125	0.00455	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STUB1—attention deficit hyperactivity disorder	0.00123	0.00447	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00122	0.00446	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00119	0.00434	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SNAP25—attention deficit hyperactivity disorder	0.00118	0.00429	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.00115	0.00419	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00114	0.00417	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00111	0.00404	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0011	0.00401	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00103	0.00376	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00101	0.0037	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00101	0.00367	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000988	0.0036	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000969	0.00353	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000936	0.00341	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000934	0.0034	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000918	0.00335	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000901	0.00329	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000887	0.00323	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000873	0.00318	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000864	0.00315	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000864	0.00315	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000859	0.00313	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000859	0.00313	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000858	0.00313	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000853	0.00311	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000848	0.00309	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000847	0.00309	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000847	0.00309	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000834	0.00304	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000824	0.003	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000816	0.00298	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000803	0.00293	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000798	0.00291	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000789	0.00288	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000785	0.00286	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000778	0.00284	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000775	0.00283	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00077	0.00281	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00077	0.00281	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000765	0.00279	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000759	0.00277	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000755	0.00275	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000747	0.00272	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000741	0.0027	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000738	0.00269	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000735	0.00268	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000723	0.00263	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000722	0.00263	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000722	0.00263	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000713	0.0026	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000709	0.00258	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000703	0.00256	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000689	0.00251	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000667	0.00243	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000665	0.00242	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000656	0.00239	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000648	0.00236	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000604	0.0022	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SNAP25—attention deficit hyperactivity disorder	0.000581	0.00212	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000553	0.00202	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000506	0.00184	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000501	0.00183	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000493	0.0018	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000465	0.0017	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000438	0.0016	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000423	0.00154	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000407	0.00148	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000399	0.00146	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000397	0.00145	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000394	0.00144	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000394	0.00144	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00039	0.00142	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000387	0.00141	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000383	0.0014	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EP300—attention deficit hyperactivity disorder	0.000382	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000357	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000351	0.00128	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000351	0.00128	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000293	0.00107	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000268	0.000977	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000261	0.000952	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00025	0.00091	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000242	0.000884	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000242	0.000884	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000239	0.00087	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000222	0.000809	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EP300—attention deficit hyperactivity disorder	0.000205	0.000746	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000194	0.000707	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EP300—attention deficit hyperactivity disorder	0.000189	0.000689	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000185	0.000673	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000163	0.000595	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000147	0.000536	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000146	0.000532	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000132	0.000482	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000113	0.000411	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000113	0.000411	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000111	0.000404	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000103	0.000376	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.01e-05	0.000329	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.58e-05	0.000313	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.83e-05	0.000249	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.78e-05	0.000247	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	6.3e-05	0.00023	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.93e-05	0.000107	CbGpPWpGaD
